TGFB1 and colitis: On the other hand, when Lactobacillus species are being studied to treat overactive immunity such as with models of colitis characterized by unchecked inflammation events, the specific changes that signify success are of those that attenuate the host immune response such as increases of the anti-inflammatory cytokines TGF-β, IL-10 and IL-22.